This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Korea Atomic Energy Research Institute. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Rae Kwon Kim: Innovator in Cancer Treatment
Introduction
Rae Kwon Kim is a notable inventor based in Sejong, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel antibodies.
Latest Patents
One of his key patents is titled "Anti-TM4SF4 antibody and uses thereof." This invention relates to novel antibodies or antigen-binding fragments that specifically bind to TransMembrane 4 Superfamily Member 4 (TM4SF4). These antibodies exhibit proliferation inhibitory activity against cancer cells, effectively preventing or treating cancer. Additionally, they reduce the self-renewal ability of cancer stem cells, making them useful in treating cancers with poor prognoses in conventional anticancer treatments. Rae Kwon Kim holds 1 patent.
Career Highlights
Rae Kwon Kim is affiliated with the Korea Atomic Energy Research Institute, where he conducts his research. His work focuses on developing innovative solutions to combat cancer, showcasing his dedication to improving patient outcomes.
Collaborations
He collaborates with esteemed colleagues, including In Gyu Kim and Jai Ha Lee, who contribute to his research efforts.
Conclusion
Rae Kwon Kim's innovative work in developing antibodies for cancer treatment highlights his commitment to advancing medical science. His contributions are paving the way for more effective cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile